Par Wants Bulk Vasopressin Compounding Nixed; FDA Agrees
By Dani Kass · August 27, 2018, 10:21 PM EDT
Just as Par Pharmaceutical asked a D.C. federal court Monday to enjoin a U.S. Food and Drug Administration policy governing bulk drug compounding, the agency agreed the same day that the...
To view the full article, register now.